How load-shifting translates to cartilage benefit

Does a brace actually protect cartilage, or does it simply reduce pain in the moment? The distinction is clinically important: a device that only masks symptoms leaves the underlying joint damage unchecked, whereas one that genuinely alters joint mechanics may slow the structural decline that ultimately leads to replacement.

In varus-aligned knees — where the joint angles inward — the medial tibiofemoral compartment absorbs a disproportionate share of load during every step. The inward-twisting force responsible for this, known as the external knee adduction moment (KAM), compresses the inner compartment against an already narrowing joint space. A valgus unloader brace counters this by applying a three-point force system that levers the knee toward a more neutral alignment, and meta-analytic evidence confirms that it consistently reduces the KAM in medial compartment osteoarthritis.

The load reduction is not merely theoretical. Biplane radiography at 100 Hz — a technique capable of capturing joint movement in real time during walking — demonstrated a statistically significant 0.3 mm increase in medial compartment dynamic joint space during gait when patients wore an unloader brace (95% CI 0.1–0.4 mm; p=0.005). Crucially, vertical ground reaction force was unchanged, confirming that the space increase reflected genuine load redistribution rather than an alteration in how patients were walking. That 0.3 mm shift is clinically relevant: cartilage matrix degrades fastest under sustained compressive overload, so even a modest, consistent reduction changes the mechanical environment the tissue must survive in.

One structural boundary is worth noting from the outset: this mechanism is specific to the medial tibiofemoral compartment. The brace does not address patellofemoral load or disease in other compartments — a limitation that shapes who genuinely benefits. If the mechanics are credible, the logical next question is whether reducing that load translates into anything measurable within the cartilage tissue itself.

What the evidence shows about tissue-level and clinical outcomes

Beck et al. (2023), published in a peer-reviewed orthopaedic journal, offered the most direct answer yet to that question. Analysing cartilage tissue biochemistry in knees subjected to sustained offloading, the study documented measurable increases in both collagen and proteoglycan concentrations within the damaged compartment — the two structural proteins that give healthy hyaline cartilage its load-bearing resilience. Finding these matrix components elevated under bracing conditions is significant: it indicates the device is not simply attenuating pain signals but altering the biochemical environment of the tissue itself, distinguishing it from a purely symptomatic intervention.

Clinical trial data adds a further layer. A 2025 randomised controlled trial enrolling 120 patients with Kellgren-Lawrence grade II–III osteoarthritis tested a combined programme of unloader bracing, static cycling, and transcutaneous electrical nerve stimulation (TENS). The combined approach held the one-year arthroplasty rate to 6.7%, against 25% in standard-care controls — a substantial difference. It is worth being clear, however, that the brace functioned as one component of a multimodal package, so that arthroplasty-rate reduction cannot be attributed to bracing in isolation. Lee et al. (2017, BMJ Open Sport & Exercise Medicine) separately confirmed that unloader bracing represents a cost-effective bridge strategy in unicompartmental knee OA, supporting delayed or reduced need for surgical intervention.

Taken together, these findings justify describing the unloader brace as a cartilage-preservation tool within a defined clinical profile — not merely a pain management device. The honest caveat is that structural evidence beyond 12 to 24 months remains sparse: long-term randomised data tracking measurable cartilage thickness change over two or more years has not yet been published.

The patient profile where bracing is most likely to help

Eligibility for unloader bracing is narrower than many patients expect — and that precision is exactly what makes it effective in the right context.

The ideal candidate presents with isolated medial tibiofemoral osteoarthritis and a varus (bow-legged) knee alignment, graded Kellgren–Lawrence II or III on imaging. In plain terms, that means measurable cartilage thinning and early-to-moderate joint space narrowing on the inner compartment, but enough surviving tissue remaining to respond to the load reduction the brace provides. At Kellgren–Lawrence grade IV — where cartilage is largely absent and bone contacts bone — the biomechanical benefit of offloading becomes negligible; there is simply not enough matrix left to preserve.

The more important population constraint is anatomical. Fewer than 5% of patients with knee osteoarthritis have truly isolated unicompartmental tibiofemoral disease. The majority present with involvement of multiple compartments, or with patellofemoral disease, or both — none of which a standard unloader brace is designed to address. Applying one in those cases does not extend the indication; it simply misses the pathology.

Within that narrow window, the strongest case for bracing belongs to younger patients with moderate varus-medial OA and clear functional goals: these are individuals where slowing structural decline carries real long-term value, and where the preserved cartilage that remains gives the brace something meaningful to protect.

The compliance problem and its clinical consequences

Even when a brace is correctly indicated and properly fitted, its clinical value depends entirely on one thing: the patient wearing it. That dependency is the single largest gap between what unloader bracing achieves in a controlled trial and what it reliably delivers in practice.

The numbers are instructive. Squyer et al. (2013) followed 89 patients prescribed an unloader brace and found that only 28% reported regular use at one year — defined conservatively as wearing the device at least twice a week for one hour at a time. By two years, that figure had fallen only marginally to 25%. More significant clinically is the finding that no parameter predicted who would continue: age, symptom severity, imaging grade, and disease extent offered no useful signal. A brace that reduces the knee adduction moment during gait only does so while being worn; the biomechanical rationale is sound, but its effect stops the moment the device is set aside.

Physical barriers compound the dropout rate. Conical leg morphology causes the frame to migrate and slip, rigid hinges generate bruising and skin irritation at the joint line, and these problems fall disproportionately on older or heavier patients. The PROP-OA qualitative study (2024), conducted across a multicentre setting, documented these barriers through patient-reported experience, confirming that adherence failure reflects structural fit and comfort problems rather than lack of motivation.

Because no baseline characteristic reliably identifies who will persist with the brace, compliance warrants explicit discussion at the assessment stage — including realistic expectations about fit, initial discomfort, and how quickly benefit may be felt. Doing so before prescription, rather than after, is the practical way to ensure the device reaches the patients most likely to use it.

When to step up: from offloading to surgical repair

Recognising when a brace has reached the limit of what it can offer is as important as knowing when to prescribe one in the first place. Two distinct clinical pathways emerge at that point, and they are not interchangeable.

Step-up to surgical realignment

For younger patients with symptomatic medial compartment OA who retain adequate surgical fitness, high tibial osteotomy (HTO) addresses the underlying varus malalignment structurally rather than compensating for it externally. A 2025 multicentre RCT (n=51, ages 18–65) put this directly to the test: HTO outperformed the valgus unloader brace on KOOS pain at 12 months by a mean difference of 28 points (95% CI −43 to −13). Where surgical realignment is appropriate, the evidence supports it as the more effective intervention — bracing in that context functions at best as a temporary measure while a decision is reached.

Step-up to focal cartilage repair

A focused area of full-thickness cartilage loss responds differently from wear spread across the joint. Diffuse degenerative OA is the domain of load management and symptomatic control; a focal full-thickness chondral or osteochondral defect — particularly in a younger patient, arising from trauma or osteochondritis dissecans, and typically under 4–6 cm² — is a structurally distinct problem that unloader bracing was never designed to treat. Left unaddressed, such defects carry a recognised risk of progression to wider degeneration, which makes the timing of the step-up clinically meaningful.

The triggers that prompt escalation are consistent: persistent symptoms despite adequate brace compliance, worsening bone-on-bone changes on serial imaging, or identification of a focal full-thickness defect that is amenable to biological repair. At that point, restoration techniques — AMIC, MACI, OATS, or osteochondral allograft for larger lesions — become the relevant discussion, each targeting structural reconstitution rather than load redistribution.

No head-to-head trial has compared unloader bracing directly against early focal cartilage repair, because the two strategies address largely non-overlapping patient phenotypes. The clinical task is recognising which phenotype is present — and which pathway that diagnosis actually calls for.

Getting the right assessment before committing to a strategy

The most difficult clinical scenario in this space is one the evidence base cannot yet resolve: a patient presenting with moderate focal cartilage loss and concurrent varus malalignment, where imaging confirms both problems but cannot determine whether offloading, realignment, or focal biological repair is the right first step — or whether some combination is appropriate. No published trial has established decision rules for this grey zone. The PROP-OA RCT (2026) — currently the largest prospective dataset on knee bracing effectiveness in osteoarthritis — provides outcome findings without yet informing specific patient-selection criteria at the boundary between these strategies; clinical decision-making here remains genuinely individuated rather than protocol-driven.

Structured specialist assessment is what bridges that gap. Symptom pattern, activity demands, the trajectory of structural change on serial imaging, and surgical fitness together distinguish the patient suited to continued offloading from the one for whom realignment is the dominant need, from the one whose focal full-thickness defect warrants biological repair. No single imaging metric resolves this: weight-bearing X-ray, MRI, and CT together establish the anatomical frame; the clinical assessment determines what that frame calls for and in what sequence. That integration — rather than any algorithm derived from imaging alone — is where the choice between strategies is actually made.

Professor Paul Y. F. Lee and the joint-preservation team at London Cartilage Clinic, based on Harley Street, offer exactly this kind of structured assessment for patients navigating these overlapping options. Patients ready to explore their pathway can arrange an initial consultation at londoncartilage.com.

1. [1] Unloader Knee Brace Increases Medial Compartment Joint Space During Gait In Knee Osteoarthritis Patients. (2018). https://doi.org/10.1007/s00167-018-5274-y https://doi.org/10.1007/s00167-018-5274-y
2. [2] Biomechanical effects of valgus knee bracing: a systematic review and meta-analysis. (2015). https://doi.org/10.1016/j.joca.2014.11.018 https://doi.org/10.1016/j.joca.2014.11.018
3. [3] Combination of Static Bike, TENS, and Unloader Knee Brace in Alleviating Knee Pain, Delaying Arthroplasty, and Improving Activities of Daily Living in Knee Osteoarthritis Patients. (2025). https://doi.org/10.61440/oajcpr.2025.v1.23 https://doi.org/10.61440/oajcpr.2025.v1.23
4. [4] Unloader brace or high tibial osteotomy in the treatment of the young patient with medial knee osteoarthritis: a randomized controlled trial. (2025). https://doi.org/10.2340/17453674.2025.42846 https://doi.org/10.2340/17453674.2025.42846
5. [5] Bracing Acceptability and Adherence for Knee Osteoarthritis: Findings from a Qualitative Study in the PROP-OA Multicentre Trial. (2024). https://doi.org/10.1016/j.joca.2024.02.789 https://doi.org/10.1016/j.joca.2024.02.789
6. [6] Knee Bracing for Knee Osteoarthritis: Findings from the PROP-OA Randomised Controlled Trial. (2026). https://doi.org/10.1016/j.joca.2026.01.585 https://doi.org/10.1016/j.joca.2026.01.585
7. [7] Clinical experiences with cartilage repair techniques: outcomes, indications, contraindications and rehabilitation. (2015). https://doi.org/10.5606/ehc.2015.19 https://doi.org/10.5606/ehc.2015.19
8. [8] Cartilage Repair with Autologous Chondrocytes (ACI Generations 1–4). (2024). https://doi.org/10.1016/j.csm.2024.08.003 https://doi.org/10.1016/j.csm.2024.08.003
9. [9] Design and Mechanical Evaluation of a Novel Multi-Compartment Unloader Knee Brace. (2019). https://doi.org/10.1115/1.4044818 https://doi.org/10.1115/1.4044818